Further evidence does not support hydroxychloroquine for patients with COVID-19

Adverse events were more common in those receiving the drug Date: May 15, 2020 Source 1: BMJ Source 2: www.sciencedaily.com Summary: The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with pneumonia Read More …